Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome
CACTuS
1 other identifier
interventional
120
1 country
1
Brief Summary
Wild-type transthyretin cardiac amyloidosis is an underdiagnosed depository disease in which fibril monomers of misfolded amyloid protein accumulates in various tissues, including the heart, and cause tissue dysfunction. Before onset of cardiac symptoms, many patients will have undergone surgery for idiopathic carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of the hand. This study investigates patients previously operated for idiopathic carpal tunnel syndrome to determine if they display signs and symptoms of cardiac amyloidosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2019
CompletedStudy Start
First participant enrolled
June 17, 2019
CompletedFirst Posted
Study publicly available on registry
June 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedOctober 8, 2021
October 1, 2021
1.5 years
June 17, 2019
October 1, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of cardiac amyloidosis.
The prevalence of cardiac amyloidosis among patients previously operated for ipiopathic carpal tunnel syndrome.
Through study completion, an average of 2 years.
Study Arms (1)
Suspicion of cardiac amyloidosis
OTHERPatients who display signs of cardiac amyloidosis will be referred for further diagnosis.
Interventions
Confirms/Refutes diagnosis of cardiac amyloidosis.
Eligibility Criteria
You may qualify if:
- Patients above sixty years of age previously operated for idiopathic carpal tunnel syndrome within the Region of Central Denmark (Region Midtjylland) the last five years.
- Informed written and verbal consent
You may not qualify if:
- Operation by different indication such as
- Fracture
- Ganglion
- Tumors
- Osteophytes
- Rheumatoid Arthritis
- Persistent medial artery
- Metabolic causes
- Alcoholism
- Hyperthyroidism
- Myxedema
- Hereditary Cardiac Amyloidosis
- Known WT ATTR
- AL Amyloidosis
- Myelomatosis
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aarhus University Hospital Skejbylead
- Regional Hospital Holstebrocollaborator
Study Sites (1)
Department of Heart Disease
Aarhus, 8200, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 17, 2019
First Posted
June 24, 2019
Study Start
June 17, 2019
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
October 8, 2021
Record last verified: 2021-10